Back to Woodline Partners LP Woodline Partners LP

NKTRNKTR
Showing 8 of 11 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in Nektar Therapeutics

Woodline Partners LP holds 470,875 shares of NKTR (Nektar Therapeutics), worth $32.9M as of 2026-Q2. The position was increased (+13.4% shares). NKTR represents 0.1% of Woodline Partners LP's portfolio.

Current Value

$32.9M

Current Shares

470,875

Total Value Change

+$30.6M

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
470,875
+13.4%
$32.9M0.1%$69.81
39
2026-Q1
Increased
415,335
+299.4%
$29.9M0.1%$68.11
56
2025-Q4
Decreased
104,000
-55.4%
$4.4M0.0%$41.90
0
2025-Q3
Decreased
233,059
-5.3%
$13.3M0.1%$58.92
0
2025-Q2
Decreased
246,145
-93.3%
$6.4M0.0%$25.76
0
2025-Q1
Decreased
3.7M
-25.8%
$2.5M0.0%$11.10
0
2024-Q4
Increased
5M
+187.3%
$4.6M0.0%$14.10
43
2024-Q3
Increased
1.7M
+178.0%
$2.3M0.0%$17.55
42

Other major holders of NKTR: BNP PARIBAS FINANCIAL MARKETS, Invesco Ltd., PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used